Categories
+ DNA
+ Nanoparticle
+ Protein
+ RNA
Protocols in Current Issue

A Multiplexed Assay for High-Throughput Evaluation of In Vitro A-to-I Editing

EG Estelle N. Gardner
KC Kyle A. Cottrell
245 Views
Nov 20, 2026

Adenosine-to-inosine (A-to-I) RNA editing, catalyzed by ADAR1, occurs on double-stranded RNA (dsRNA) and plays a key role in innate immunity. Editing of endogenous dsRNAs prevents aberrant activation of dsRNA sensors and resulting inflammation. This function of ADAR1 is essential in many cancers, making ADAR1 a promising therapeutic target. Current approaches for measuring A-to-I editing in biochemical assays, which often rely on Sanger sequencing, are limited in throughput. Thus, there is a need to develop high-throughput A-to-I editing assays to enable efficient screening of potential ADAR1 inhibitors. We developed a new high-throughput A-to-I editing assay that uses barcoded reverse-transcription primers to enable pooling and sequencing of multiple assays performed in parallel. Starting from an existing Sanger-based method, we optimized aspects of the A-to-I editing reaction, cDNA synthesis, and downstream processing to facilitate high-throughput assays and substantially lower per-reaction costs. In brief, immediately following the A-to-I editing reaction, cDNA is synthesized using well-specific barcoded reverse-transcription primers. Subsequently, cDNA from all reactions is pooled and processed as one sample for next-generation sequencing, with the potential for further multiplexing by indexed sequencing adapters. Our approach enables parallel measurement of RNA editing under multiple conditions in a plate-based format while significantly reducing the time, labor, and costs required compared to traditional methods. This high-throughput assay provides a scalable platform for screening ADAR1 inhibitors and may accelerate the development of targeted therapies for cancer.

Identification of Proteins Interacting With Target lncRNAs Using In Vitro Biotinylated RNA Pull-Down Assay and Mass Spectrometry

Identification of Proteins Interacting With Target lncRNAs Using In Vitro Biotinylated RNA Pull-Down Assay and Mass Spectrometry

KJ Kristen John
KD Kayleigh Diveley
NM Nasif Mahmood
AI Alexandra Istishin
XP Xinxia Peng
144 Views
Nov 20, 2026

Once considered “junk” transcription, long noncoding RNAs (lncRNAs) are now known to play key regulatory roles within biological processes such as transcription and translation. As lncRNAs have low translational potential, they often interact with proteins to exert their molecular functions. Therefore, identifying the protein interacting network of a lncRNA is critical to investigating its potential function. While in vivo methods exist to identify RNA–protein partners, these often require high cell inputs and RNA expression, which can be challenging for lowly expressed lncRNAs. Alternatively, in vitro methods require lower inputs, but many of these methods do not use a standardized protocol across publications or describe how the identified proteins are prioritized for further validation. Here, we describe an RNA pull-down assay using the lncRNA VILMIR as an example, which can be adapted for other lncRNA targets. First, the lncRNA was in vitro transcribed and internally biotinylated and then incubated with cellular lysate to identify interacting proteins by mass spectrometry. In addition, we describe the resulting mass spectrometry analysis and how the identified proteins were prioritized for further validation and follow-up experiments. This protocol has been successfully reproduced for multiple proteins and can be scaled up or down as needed.

A Step-by-Step UniDesign Protocol for the Fully Computational Design of PAM-Relaxed CRISPR–Cas Point-Mutation Variants

A Step-by-Step UniDesign Protocol for the Fully Computational Design of PAM-Relaxed CRISPR–Cas Point-Mutation Variants

EW Ethan S. Wang
JX Jayson Z. Xu
KT Kristijan Tomić
YC Y. Eugene Chen
XH Xiaoqiang Huang
458 Views
Nov 20, 2026

Engineering CRISPR nucleases with expanded protospacer-adjacent motif (PAM) compatibility can increase the number of genomic sites accessible to genome editing. This protocol describes a fully computational UniDesign workflow for engineering point-mutant Staphylococcus aureus Cas9 (SaCas9) variants with relaxed PAM recognition. Starting from the SaCas9–sgRNA–DNA complex structure, the protocol provides step-by-step instructions for installing and configuring UniDesign, preparing PAM-altered structural models, selecting mutable and repackable residues, constructing RESFILEs, performing three iterative design steps, and analyzing the resulting variants. The first step identifies substitutions that reduce energetic discrimination among four PAM models, yielding R1015H as the fixed background for subsequent design. The second step searches for compensatory mutations that restore protein–DNA binding strength through favorable, sequence-independent interactions. The third step combines promising substitutions to generate and prioritize triple mutants based on mean PAM-binding energy, mean absolute deviation, and structural plausibility. Designed for users with limited computational experience, this protocol enables reproduction of the SaCas9 PAM-relaxation workflow and provides an adaptable framework for engineering other protein–nucleic acid interactions.

Protocols in Past Issues

Transcriptomic Signature-Guided EGFP Labeling of Alveolar Epithelial Cells via RNA Sensing in Mouse Lungs In Vivo and Human Idiopathic Pulmonary Fibrosis Lung Slices Ex Vivo

ZZ Zhen Zheng
CJ Chun-sun Jiang
DS Dan Shan
CH Chao He
IR Ivan O. Rosas
JL Joseph A. Lasky  [...]
YZ Yong Zhou
+ 1 Author
550 Views
Nov 5, 2026

Single-cell RNA sequencing has revealed transient and disease-associated alveolar epithelial states that are difficult to access with conventional transgenic approaches. Here, we describe a programmable RNA-sensing workflow based on CellREADR [cell access through RNA sensing by endogenous adenosine deaminases acting on RNA (ADAR)] to couple a selected cellular RNA signature to enhanced green fluorescent protein (EGFP) translation. The protocol covers sequence-encoded sensing RNA (sesRNA) design and cloning, in vitro validation of sesRNA-dependent EGFP expression in HEK293T cells, production and heparin-column purification of adeno-associated virus variant 6.2FF (AAV6.2FF), delivery to mouse lungs, and application to human idiopathic pulmonary fibrosis (IPF) precision-cut lung slices (PCLS). Sensors targeting Sftpc, Pdpn, or Sprr1a can be used to label alveolar type 2, alveolar type 1, and injury-induced Krt8+ alveolar differentiation intermediate cells in mice and KRT17+KRT5- aberrant basaloid cells in humans, respectively. Because cell specificity is programmed by the sensor sequence rather than a cell type–specific promoter or newly generated mouse line, this approach can be rapidly adapted to emerging transcriptomic targets in both experimental mouse models and human lung tissues, enabling cross-species validation and translational investigation of disease-associated epithelial states.

A Batch-Processing Pipeline for RNA-seq Gene Abundance Estimation

JL Juan S. Zambrano Leiton
KL Karen E. López
AR Angie F. Riascos-España
CG Claudia E. Salazar Gonzalez
CG Carlos A. Betancourth García
PV Pedro A. Velasquez-Vasconez
723 Views
Nov 5, 2026

RNA sequencing (RNA-seq) datasets provide valuable opportunities to investigate gene and transcript abundance across species, tissues, developmental stages, and experimental conditions. However, processing multiple datasets consistently remains challenging because sequencing runs may differ in library layout, read length, sequencing depth, metadata quality, and analytical settings. Existing RNA-seq workflows often depend on dedicated workflow managers, substantial computational infrastructure, or advanced bioinformatics expertise, which may limit their accessibility for routine analyses. We present a modular Bash- and Python-based batch-processing pipeline for estimating gene and isoform abundance and generating expression matrices from multiple RNA-seq runs. Using an SRA RunTable, a reference genome, and its corresponding gene annotation, the workflow automates reference preparation, sequencing-data retrieval, quality assessment, read preprocessing, alignment, abundance estimation, and post-processing. It produces gene-level TPM and FPKM matrices, individual gene- and isoform-level RSEM outputs, quality-control summaries, and integrated MultiQC reports. Configurable computational resources, sample-level status tracking, automatic download retries, selective reprocessing of failed samples, and controlled removal of intermediate files allow interrupted analyses to resume without repeating completed runs while reducing storage requirements. By combining batch processing, transparent configuration, and restartable execution in a lightweight workflow, this protocol provides an accessible approach for standardized RNA-seq abundance estimation.

An Improved Method for Rapid Unmarked Gene Deletion in Bacteria: Pseudomonas aeruginosa as an Example

JZ Junlu Zhang
PW Ping Wang
XZ Xin Zhang
QW Qing Wei
KC Kaiyu Cui
1271 Views
Oct 20, 2026

The release and updating of whole-genome sequences of several representatives of the human opportunistic pathogen Pseudomonas aeruginosa have laid the ground for investigating the mechanisms of antibiotic resistance, biofilm formation, and virulence, while also offering opportunities for researchers to find new therapeutic targets to control this bacterium using a functional genomics approach. However, there is still a lack of detailed protocols describing gene inactivation methods in P. aeruginosa, resulting in failures and extra time spent designing in-house protocols. Here, we introduce a rapid, efficient, and unmarked deletion mutagenesis method combining overlap extension PCR, efficient conjugation, and the traditionally used sacB-based counter-selection procedure. Efficient generation of deletion mutants using this detailed protocol can be easily completed in one week using standard lab reagents. Importantly, this method may be adaptable to other bacteria where the sacB-based counter-selection system works.

Optimized Phenol–Chloroform–Isoamyl DNA Extraction Protocol for Single Fish Eggs

IŽ Iva Žužul Vrgoč
IL Ivana Lepen Pleić
KI Klara Ivanišević
TŠ Tanja Šegvić-Bubić
985 Views
Oct 20, 2026

Reliable DNA extraction is essential for genetic research on marine species; however, obtaining sufficient DNA from single fish eggs remains challenging. Existing protocols often require optimization to achieve high PCR efficiency. The optimized phenol–chloroform–isoamyl extraction protocol presented in this paper improves DNA yield and quality from individual eggs of Atlantic bluefin tuna (Thunnus thynnus), bogue (Boops bops), saddled seabream (Oblada melanura), and painted comber (Serranus scriba) by modifying buffer volumes, incubation times, and washing steps, following prior micropuncturing of eggs on a glass slide. DNA quality is confirmed by spectrophotometry, PCR amplification of the mitochondrial COI gene, electrophoresis, and Sanger sequencing. This method provides a low-cost and effective approach for species identification from individual fish eggs.

Immune-Complex-Based In Vitro Deubiquitination Assay

FD Florence Dô
SM Sylvain Meloche
MS Marc J. Servant
1363 Views
Oct 5, 2026

Deubiquitinases (DUBs) are attractive therapeutic targets within the ubiquitin-proteasome system, in part because four of the five DUB subfamilies are cysteine proteases amenable to the development of potent, selective inhibitors, as recently demonstrated for USP7. Identifying DUBs that deubiquitylate and stabilize specific human oncogenic proteins is therefore a promising approach to discovering new mechanism-based targets for cancer therapy. Several complementary experimental strategies are typically required to identify bona fide DUB–substrate pairs. Here, we present an efficient, straightforward in vitro immune-complex protocol to validate USP17-mediated deubiquitylation of the transcriptional co-activator β-catenin. In this assay, both β-catenin and USP17 are immunopurified from transiently transfected 293T cells and then combined to assess USP17 enzymatic activity. The protocol describes the in vitro enzymatic assay performed on immunopurified complexes and the immunoblot-based readout. It can be readily adapted to other DUBs and substrates for mechanistic studies.

A SPAAC-Based Bioorthogonal Method for Verifying Protein Palmitoylation

YZ Yaoyu Zhang
JL Jiahui Li
XP Xinxin Pei
TM Tengfei Ma
YW Yi Wang
BZ Buchang Zhang
CX Changzhi Xu
1217 Views
Sep 20, 2026

Palmitoylation is a crucial post-translational modification, and bioorthogonal chemistry based on azide-alkyne cycloaddition is typically used to verify protein palmitoylation. Traditional copper-catalyzed click chemistry (CuAAC) proceeds with fast kinetics and is widely used, but it requires a copper catalyst and suffers from copper-induced toxicity and nonspecific labeling. By contrast, strain-promoted click chemistry (SPAAC) has slower kinetics but is catalyst-free, offering high specificity, low cytotoxicity, and simple operation. However, SPAAC is mostly applied to live-cell labeling and imaging of known palmitoylated proteins in the field of palmitoylation, and its use in identifying novel palmitoylated proteins is still limited. Here, we present a SPAAC-based method for detecting endogenous protein palmitoylation. Compared with CuAAC, this method eliminates the need for copper catalysts and reducing agents, thereby simplifying the procedure and reducing reagent usage.

How to Perform a Tracer Displacement BRET Assay for the TRPML1 Ion Channel

MC Micael R. Cunha
CC Carolina M. C. Catta-Preta
KM Katlin B. Massirer
RC Rafael M. Couñago
1420 Views
Sep 20, 2026

The transient receptor mucolipin subtype 1 (TRPML1) is a ubiquitously expressed ion channel involved in lysosomal homeostasis. Recent pharmaceutical interest in developing agonist ligands has emerged due to beneficial effects in neurodegenerative diseases. The major high-throughput screening techniques to investigate this ion channel involve fluorescent calcium imaging and electrophysiology. Despite their high capacity for screening compounds, it is well known that both methods face hurdles, such as the need for expensive, specialized equipment. Here, we present a novel technique to screen for ligands of TRPML1 using a bioluminescence resonance energy transfer (BRET) assay. This assay consists of a target engagement assay in live cells, which permits the determination of binding constants between ligands and the target of interest in equilibrium or time-dependently. We employ a full-length TRPML1 C-terminally tagged with the small bioluminescent protein nanoluciferase. This ensures the correct localization of the ion channel in the lysosomal membrane and an optimal placement of the luciferase in the cytoplasm. We also developed a cell- and lysosome-permeable fluorescent BRET tracer that gives a BRET signal only when bound to the ion channel. This new protocol allows researchers worldwide to screen compounds that would interact with TRPML1 by using any plate reader with luminescent and fluorescence filters.

Protecting Against Cytoplasmic Protein Aggregates With Cytoplasmic PML Variants

JZ Jia-Xin Zhu
YX Yuchen Xia
JL Jiaqi Liu
LC Li Cao
SH Steven X. Hou
YW Yang Wang
1059 Views
Sep 20, 2026

Cytoplasmic protein aggregation is a defining feature of multiple neurodegenerative diseases, including amyotrophic lateral sclerosis, frontotemporal dementia, Huntington’s disease, and certain forms of motor neuron disease. Recent evidence indicates that promyelocytic leukemia protein (PML) and engineered PML-derived variants can act as versatile aggregate-remodeling factors. In particular, cytoplasmically redirected PML variants recognize pathological cytoplasmic inclusions and promote their clearance. Here, we describe a protocol to generate and validate two engineered cytoplasmic PML variants: full-length mPML, which is redirected to the cytoplasm by disruption of its nuclear localization sequence, and the truncated mPMLΔRBC variant, which lacks the RING, B-box, and coiled-coil domain but retains aggregate-reducing activity. The protocol integrates fluorescence-based imaging, bimolecular fluorescence complementation, detergent-soluble/insoluble fractionation, and validation in primary rat cortical neurons. This workflow provides a practical platform for assessing cytoplasmic aggregate burden and for comparing the aggregate-remodeling activities of PML-derived constructs. It can also be adapted to other disease-associated aggregation-prone proteins, including TDP-43, SOD1, FUS, tau, polyGA, and polyQ-expanded proteins.

Homogeneous Time-Resolved Fluorescence-Based Assay to Screen ADP-Ribosyl Hydrolase Inhibitors

AY Alice Yu
DW Duo Wu
1432 Views
Sep 20, 2026

ADP ribosylation (ADPr) is a crucial post-translational modification that plays a vital role in DNA damage repair. Catalyzed by ADP ribose polymerases using NAD+ as a substrate, ADPr activates DNA repair pathways rapidly, thereby maintaining genomic integrity. The involvement of ADP ribose hydrolases in this process is significant, as they hydrolyze PAR chains, facilitating the release of ADPr-modified proteins from DNA or other proteins, which is essential for subsequent DNA repair steps. This protocol outlines a high-throughput screening method for identifying inhibitors of ADP ribose hydrolases, utilizing His-Tb-conjugated and ADPr-modified His-ADP ribose polymerase as the signal donor, and GST-d2-conjugated GST-XRCC1 as the signal receptor. The detection of time-resolved fluorescence signals enables efficient evaluation of compounds with potential therapeutic activity against cancer.

Identifying D-Group Mitogen-Activated Protein Kinases as Substrates of Arabidopsis Tyrosine Phosphatase RLPH2 Using Phospho-Tyrosine Peptide Enrichment

AL Anne-Marie Labandera
BK Brooklyn Kurucz
RU R. Glen Uhrig
GM Greg B. Moorhead
828 Views
Sep 5, 2026

Identifying substrates of protein phosphatases has been technically challenging and has hampered progress in the field of plant sciences. Small molecule inhibitors of protein phosphatases have aided in uncovering classes of phosphatases that target substrates, but that too has severe limitations. Here, we describe a method that enriches phosphorylated substrates using TiO2 and phospho-tyrosine antibodies in phosphatase knockout lines of Arabidopsis thaliana. When compared to wild-type plants, this approach permits identification of putative substrates and specific phosphorylation sites by mass spectrometry, allowing for further in vitro or functional validation. The key to the approach described here is the use of phosphatase knockout lines to maintain substrates in a phosphorylated state and using phospho-tyrosine antibodies to enrich for tyrosine phosphorylated peptides.

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 105